Acridine

Acridine

SCHEMBL27860754

NC=O.c1ccc2nc3ccccc3cc2c1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.71
MAPT P10636 5/20 0.71
HPGD P15428 3/20 0.71
GLA P06280 2/20 0.71
ACHE P22303 1/20 0.71
HTR3A P46098 1/20 0.57
KDM4E B2RXH2 6/20 0.50
NPC1 O15118 5/20 0.50
GAA P10253 5/20 0.50
RAB9A P51151 4/20 0.50
KMT2A Q03164 3/20 0.50
POLB P06746 3/20 0.50
LMNA P02545 1/20 0.50
PTBP1 P26599 1/20 0.50
RCE1 Q9Y256 1/20 0.50
NQO2 P16083 1/20 0.48
TLR8 Q9NR97 1/20 0.47
IKBKB O14920 1/20 0.46
MEN1 O00255 2/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acridine SCHEMBL29114524 0.86 ALDH1A1 (0.71) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL27450140 0.86 ALDH1A1 (0.71) ALDH1A1MAPTHPGDGLAACHE
Phenazine SCHEMBL27991538 0.85 MAPT (0.65) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL4972293 0.84 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL29352289 0.84 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL3045498 0.84 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL1772714 0.84 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL8339 0.84 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL28830169 0.82 MAPT (0.83) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL28646458 0.82 ALDH1A1 (0.83) ALDH1A1MAPTHPGDGLAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117897380-A Pyridazinone or pyridone compounds, process for their preparation and their use 益方生物科技(上海)股份有限公司 2024-04-16 CN disclosed
CN-117298275-A Method for treating hematological malignancies and ewing's sarcoma 库拉肿瘤学公司 2023-12-29 CN disclosed
CN-114867726-B Small molecule inhibitors of KRAS G12C mutants 默沙东有限责任公司 2023-11-28 CN disclosed
CN-115968286-A Heteroaryl compounds, their preparation and use 益方生物科技(上海)股份有限公司 2023-04-14 CN disclosed
CN-112040979-A Antibodies to signal-modulating protein alpha and methods of use ALX肿瘤生物技术公司 2020-12-04 CN disclosed
CN-110526912-A Heteroaryl compound for kinase inhibition ARIAD PHARMA INC 2019-12-03 CN disclosed
CN-110461872-A CD47 antigen binding units and uses thereof ZAI LAB SHANGHAI CO LTD 2019-11-15 CN disclosed
CN-110382482-A Condensed miscellaneous-Heterobicyclic compounds and its application method 亚瑞克西斯制药公司 2019-10-25 CN disclosed
CN-110382483-A Condensed N- heterocyclic compound and its application method 亚瑞克西斯制药公司 2019-10-25 CN disclosed
CN-110366550-A Benzoisothiazole, isothiazolo [3,4-b ] pyridine, quinazoline, phthalazine, pyrido [2,3-d ] pyridazine and pyrido [2,3-d ] pyrimidine derivatives as KRAS G12C inhibitors for the treatment of lung, pancreatic or colorectal cancer 美国安进公司 2019-10-22 CN disclosed
CN-105189456-B Covalent inhibitors of KRAS G12C 亚瑞克西斯制药公司 2017-12-19 CN disclosed
CN-106559991-A Heteroaryl compounds for kinase inhibition 阿里亚德医药股份有限公司 2017-04-05 CN disclosed
CN-106488910-A Inhibitors of kras g12c 亚瑞克西斯制药公司 2017-03-08 CN disclosed
CN-103025758-B IL-1 binding proteins ABBVIE 公司 2017-01-18 CN disclosed
CN-105492011-A Therapeutic synergy of undesirable chemical compounds BROWN DENNIS M 2016-04-13 CN disclosed
CN-105228649-A HCV antigen-antibody combination assays and methods and compositions for use therein ABBOTT LAB 2016-01-06 CN disclosed
CN-104203278-A IL-1 binding proteins ABBVIE INC 2014-12-10 CN disclosed
CN-103476250-A Compositions and methods for improving the therapeutic efficacy of suboptimally administered compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol DEL MAR PHARMACEUTICALS 2013-12-25 CN disclosed
CN-103002738-A Chemical compounds, compositions and methods for kinase modulation INTELLIKINE INC 2013-03-27 CN disclosed
CN-102271513-A Benzoxazole kinase inhibitors and methods of use 2011-12-07 CN disclosed